Ignite Creation Date:
2025-12-25 @ 4:25 AM
Ignite Modification Date:
2026-03-11 @ 5:34 AM
Study NCT ID:
NCT06351020
Status:
RECRUITING
Last Update Posted:
2025-09-12
First Post:
2024-03-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
LM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma.
Sponsor:
LaNova Medicines Zhejiang Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
LM302-03-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None